David Goldschneider

Title: David Goldschneider: Innovator in Cancer Treatment

Introduction

David Goldschneider is a notable inventor based in Villeurbanne, France. He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic strategies.

Latest Patents

Goldschneider holds a patent for a groundbreaking invention titled "Combined treatment with Netrin-1 interfering drug and immune checkpoint inhibitors drugs." This invention focuses on the combined use of a compound that disrupts the interaction between netrin-1 and its receptors, known as a NTN1 neutralizing agent, along with immune checkpoint inhibitors for cancer treatment. The composition may involve an anti-netrin-1 antibody and an immune checkpoint inhibitor, which can be administered simultaneously, separately, or sequentially to patients.

Career Highlights

Throughout his career, Goldschneider has worked with prominent organizations, including Netris Pharma and Université Claude Bernard—Lyon 1. His work has been instrumental in advancing cancer therapies and improving patient outcomes.

Collaborations

Goldschneider has collaborated with notable colleagues such as Benjamin Ducarouge and Anna Maria Rita Redavid, contributing to the development of innovative cancer treatments.

Conclusion

David Goldschneider's contributions to cancer treatment through his patent and collaborations highlight his role as a significant innovator in the medical field. His work continues to pave the way for advancements in therapeutic strategies against cancer.